Novo Nordisk, Inc. · Class II · Cleared Dec 17, 2018
| K-number | K182387 |
| Device name | NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) |
| Applicant | Novo Nordisk, Inc. |
| Product code | FMF |
| Device class | Class II |
| Decision date | Dec 17, 2018 |
| Decision | Substantially Equivalent |
| Regulation | 880.5860 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov